ArticleBritish journal of cancer2026

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Pietro Guerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.